US Patent 11072781 Genomic engineering of pluripotent cells
Patent 11072781 was granted and assigned to Fate Therapeutics Inc on July, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11072781 Genomic engineering of pluripotent cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
